Prescription delays for indigenous patients amount to triage by race


Leave a Comment

Enter the debate: reply to an existing comment
2 comments

  1. Graham MacKenzie Ph.C

    I Respectfully disagree with the race triage description especially based on the volume of meds they cover. This is a drug plan and I think you simplify the “ease” of dealing with other plans and the wait times. I work with many including NIHB and yes waits at times can be long but our major complaint is sometimes the physician or OT not getting back to them in a timely manner, which leaves the claim in flux. We’ve all had struggles with most plans in approvals that get hung up for what seems like a long time. It comes down to “this is your plan and this is what it covers”. Anything beyond that for any plan is a crap shoot unless it follows predetermined set of steps in which case the code system kicks in.

  2. Margaret

    Yes, the same argument can be made – of systemic discrimination- about the effects of physician gatekeeping that restricts access to many health care services, including imaging, specialist consultation and remedial surgery. If you look at population health statistics in this country, you will find that certain patient populations are more adversely affected than others by gatekeeping practices and by limited prescription coverage. Chronic care patients are a particular target of restricted access to health care. We also have a two tiered health care system that allows private paying patients to jump ahead of wait lists, leaving Medicare patients with 2 and 3 year waits or more for specialist care and surgeries. Physicians are leaving Medicare, and reducing their time in public health, setting up private practice instead. That is time lost to Medicare insured patients, and that lost time is not being replaced by hiring more physicians and specialists. Good for the doctors pocket books, but not good for public health.

Submit a comment